Company Filing History:
1 out of 723 
1 out of 135 Years Active: 2015
Title: Innovations by Sergio Peano in Autoimmune Disease Treatment
Introduction
Sergio Peano is an accomplished inventor based in Ivrea, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach combines various therapeutic agents to enhance treatment efficacy.
Latest Patents
Sergio Peano holds a patent for a novel combination therapy titled "Combination of BLyS inhibition and anti-CD20 agents for treatment of autoimmune disease." This invention relates to innovative therapies that involve the inhibition of BLyS or BLyS/APRIL alongside anti-CD20 agents. The preferred method includes using a BLyS antagonist, which can be a Fc-fusion protein, such as a TACI-Fc-fusion protein, a BAFF-R-Fc-fusion protein, or a BCMA-Fc-fusion protein. The methods aim to reduce B cell levels in patients suffering from autoimmune diseases, utilizing agents like RITUXAN® (rituximab), ocrelizumab, and ofatumumab.
Career Highlights
Throughout his career, Sergio Peano has worked with notable companies, including Zymogenetics, Inc. and Ares Trading S.a. His experience in these organizations has contributed to his expertise in developing innovative therapies for complex medical conditions.
Collaborations
Sergio has collaborated with esteemed professionals in his field, including Rafael A Ponce, Jr. and Herve Broly. These collaborations have further enriched his research and development efforts.
Conclusion
Sergio Peano's innovative work in the treatment of autoimmune diseases showcases his dedication to advancing medical science. His patent reflects a significant step forward in therapeutic strategies, potentially improving the lives of many patients.